PUBLISHER: iData Research Inc. | PRODUCT CODE: 2034963
PUBLISHER: iData Research Inc. | PRODUCT CODE: 2034963
Please contact us using the inquiry form for pricing information.
The global vascular access device market was valued at $13 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.4%, reaching nearly $15.3 billion by 2032.
This report covers the global market for vascular access devices and accessories, including implantable ports, port needles, CVCs, PICCs, PIVCs, EDCs, midlines, dialysis catheters, tip-placement systems, catheter securement, antibacterial patches, catheter caps, syringes, and needles.
The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.
Market growth is supported by conversion to power-injectable devices, conversion to safety products, and a gradual shift toward higher-value vascular access technologies. However, training requirements and infection risk continue to limit adoption in certain segments.
Market Overview
The global vascular access device market includes a broad set of products used to provide venous access for medication delivery, blood draws, contrast injection, dialysis, infusion therapy, and longer-term treatment pathways.
The market includes both high-volume short-term products, such as PIVCs, syringes, and needles, and higher-value products, such as implantable ports, PICCs, midlines, and advanced securement systems. This wide scope reflects the central role of vascular access across hospital, outpatient, and chronic care settings.
Growth in the market is being driven more by shifts in product mix than by pure volume expansion. Higher-value and more complex devices are gradually accounting for a larger share of total market value, while short-term products face more mature demand dynamics.
This mix shift continues to support overall market value growth, although adoption varies across regions. Developed markets are more likely to adopt premium safety, power-injectable, and advanced placement technologies, while emerging markets may continue expanding access through more basic vascular access products.
Market Drivers
Conversion to Power-Injection
Conversion to power-injectable devices is a major driver of the vascular access market. Many long-term vascular access devices, including ports, CVCs, and PICCs, are now available in power-injectable configurations required for computed tomography contrast media.
These devices carry a price premium over conventional alternatives. As hospitals increase their use of CT imaging and require vascular access devices that can support contrast injection, demand is shifting toward higher-value configurations.
The transition to power-injectable devices supports growth in overall unit sales while helping sustain ASPs. This is especially important in mature segments where volume growth alone may not be enough to drive strong market expansion.
Conversion to Safety Products
Conversion to safety products is another important driver. Many countries have implemented legislation requiring the use of safety devices to reduce needlestick injuries among healthcare workers and patients.
These standards require employers to identify risks, evaluate safer medical devices, maintain sharps injury logs, and involve healthcare workers in selecting safety products. As a result, safety devices have become the standard in several vascular access categories.
Some segments, such as PIVCs in acute care settings, have already achieved high conversion rates. However, the global transition is not complete. Many countries have yet to implement strong safety requirements, leaving room for future adoption of premium-priced safety products.
Shift Toward Higher-Value Devices
The market is also being supported by a shift toward higher-value vascular access products. Implantable ports, PICCs, midlines, and advanced securement solutions are gradually accounting for more of total market value.
These products often provide longer dwell times, improved workflow, better patient management, or specialized use in oncology, infusion therapy, dialysis, or long-term care.
This shift helps sustain market value even when high-volume product categories mature. As hospitals adopt more advanced vascular access strategies, product mix will remain a key driver through 2032.
Market Limiters
Education and Training
Education and training requirements continue to limit growth in the vascular access market. New vascular access products often require staff training to ensure proper use.
Training can be expensive and time consuming. Nurses have shown interest in learning how to use new vascular access technologies, but physicians may be more reluctant to receive training and often prefer devices they already know.
If proper training is not completed, adoption of new devices can be limited. This affects advanced products such as tip-placement systems, power-injectable devices, and newer catheter technologies where correct use is important to safety, workflow, and outcomes.
High Infection Rate
Infection risk remains an important limiter, especially in central venous access. Vascular access devices can create a pathway for infection, and central venous access is often used only when other options are not sufficient.
Dialysis catheters have higher infection rates than arteriovenous fistulae or AV grafts. As long as alternatives with lower infection rates are available, use of certain vascular access devices may be limited.
This risk also increases demand for infection prevention accessories, including antibacterial catheter patches, securement devices, and catheter caps. However, the underlying infection risk can still limit broader adoption of certain access methods.
Mature High-Volume Segments
Several high-volume vascular access categories are mature. Products such as conventional PIVCs, syringes, and needles are widely used and already have established adoption across many healthcare systems.
In these segments, growth is often constrained by price competition, procurement pressure, and limited differentiation. Even when unit volumes remain high, ASP growth can be difficult to achieve.
As a result, overall market expansion depends more heavily on premium devices, safety conversion, power-injectable products, and higher-complexity categories rather than basic high-volume products alone.
Market Coverage and Data Scope
Markets Covered and Segmentation
The extended dwell catheter market is analyzed as part of the broader vascular access device market.
This segment covers systems and accessories used to support accurate vascular access placement.
This segment covers patches used to reduce infection risk around catheter insertion sites.
This segment covers catheter caps used as part of vascular access management.
Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
Competitive Analysis
In 2025, Becton Dickinson led the global vascular access device and accessories market. The company maintained a strong presence across both core vascular access devices and adjunct product categories.
BD has continued to strengthen its position through portfolio expansion and integration of advanced clinical solutions. Its broader hospital offering includes vascular access, infection prevention, workflow efficiency, and critical care support.
Ongoing product innovation has reinforced BD's leadership across most segments covered in this report. The company's scale, clinical relationships, and broad vascular access portfolio support its competitiveness in both mature and higher-growth categories.
B. Braun remained one of the leading competitors in 2025, supported by a broad portfolio spanning peripheral and central access solutions. The company has a strong presence in PIVCs and CVC systems, with integrated support for ECG-guided tip positioning.
B. Braun also participates in implantable ports and port access needles, strengthening its exposure across multiple vascular access segments. The company maintains a smaller but established footprint in syringes and needles.
Cardinal Health competed primarily through syringes and needles and selected catheter securement products. Leveraging its scale as a global manufacturer and distributor, Cardinal Health maintains a strong presence in high-volume consumables supplied to hospitals and alternate-site care settings, while remaining less exposed to higher-complexity vascular access device segments.
Technology and Practice Trends
Power-Injectable Device Adoption
Power-injectable ports, CVCs, and PICCs are becoming more important as CT contrast media use increases. These devices support imaging workflows and carry higher ASPs than conventional products.
Their growing use is shifting market value toward premium long-term access devices.
Safety Device Conversion
Safety devices are expected to become the standard of care in many vascular access procedures. Legislative requirements and needlestick prevention efforts are supporting continued conversion.
Future adoption in countries without strong safety mandates could create additional growth.
Tip-Placement Support
Tip-placement systems and accessories are gaining importance as providers focus on accurate catheter placement and workflow efficiency.
These systems can help reduce placement uncertainty and support more consistent vascular access procedures.
Infection Prevention
Infection prevention remains central to vascular access care. Antibacterial catheter patches, catheter caps, and securement products help reduce infection risk and support safer access management.
This trend is especially important in central venous and dialysis access.
Long-Term Access Growth
Higher-value devices such as implantable ports, PICCs, and midlines are becoming more important to total market value. These products support longer dwell times and more specialized therapy needs.
Their growth reflects a shift away from basic short-term access toward more tailored access strategies.
Mature Consumable Competition
High-volume consumables, including PIVCs, syringes, and needles, face mature demand and strong price pressure. Companies competing in these categories must manage volume, procurement expectations, and safety conversion.
This trend limits ASP growth in basic product categories.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Vascular Access Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand product mix shifts, and support commercial planning in the global vascular access device market.
Global Vascular Access Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Key Report Updates
Version History
Global Vascular Access Market Overview
Please contact us using the inquiry form for pricing information.